SALT LAKE CITY, Nov. 5, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
HOUSTON, Nov. 5, 2024 /PRNewswire/ -- At the Society for Immunotherapy of Cancer (SITC) Annual Meeting (Nov. 6-10, 2024), Complete…
Company Poised to Revolutionize Breast Cancer Screening through AI-based Risk Prediction BOSTON, Nov. 5, 2024 /PRNewswire/ -- Clairity, Inc., a…
The Behavioral Health Tech 2024 (BHT2024) conference is a premier event dedicated to advancing access to mental health, substance use,…
DENVER, Nov. 4, 2024 /PRNewswire/ -- At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete…
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…
Setting New Standards in Workers' Compensation DocumentationKENOSHA, WI / ACCESSWIRE / November 4, 2024 / OccuPro, a leader in industrial…
LEXINGTON, Ky. , Nov. 2, 2024 /PRNewswire/ -- The Association of Biomolecular Resource Facilities (ABRF) is pleased to announce the selection…
SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ -- Wasatch Biolabs (WBL), a disruptive R&D and high-throughput…
New, groundbreaking technology delivers Illumina's most comprehensive genome yet; early results from Broad Clinical Labs demonstrate a highly simplified workflow,…